Ana Sofia Reis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ana Sofia Reis has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Ana Gorgulho
Infectious Diseases Department, Unidade Local de Saúde de Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal
1 shared publication Ana Rita Paixão
School of Medicine, University of Minho, Braga, Portugal
1 shared publication- Celina Gonçalves
Infectious Diseases Department, ULS Gaia e Espinho, Vila Nova de Gaia, Portugal
1 shared publication - Cristóvão Figueiredo
Infectious Diseases Department, ULS Gaia e Espinho, Vila Nova de Gaia, Portugal
1 shared publication - Dara Mbanze
Infectious Diseases Department, ULS Gaia e Espinho, Vila Nova de Gaia, Portugal
1 shared publication Gabriela Abreu
Microbiology Department, ULS Gaia e Espinho, Vila Nova de Gaia, Portugal
1 shared publication
Latest Publications
- Open Access
- 19 August 2026
- Published by Springer Nature in Discover Medicine
- Vol. 3 (1) , 111
Epidemiology and predictors of 30-day mortality in clinically significant Clostridium species infections
Purpose: Clostridium species are an under-recognized cause of severe infections with substantial mortality, yet national data remain limited. This study aimed to characterize the epidemiological, microbiological, clinical, and therapeutic features of clinically significant Clostridium spp. infections and to identify factors associated with 30-day mortality. Methods: We conducted a retrospective, single-centre cohort study at Unidade Local de Saúde de Gaia-Espinho (Portugal), including all patients with clinically significant Clostridium spp. isolates between 1 January 2020 and 30 March 2025. Demographic, clinical, microbiological, and therapeutic data were obtained from electronic medical and laboratory records. The primary outcome was 30-day all-cause mortality. Survivors and non-survivors were compared using univariate and multivariable logistic regression analyses. Results: A total of 119 patients were included (median age 68.9 years). Most infections were community-acquired (73.1%), and C. perfringens was the most frequently identified species (58.8%). Thirty-day mortality was 22.7%. In univariate analysis, mortality was associated with older age, thrombocytopenia, hepatic and renal dysfunction, bacteremia, sepsis or septic shock, inadequate antimicrobial therapy, and lack of source control. In Firth penalised logistic regression, age (OR 1.09/year, 95% CI 1.04–1.16), hepatic dysfunction (OR 6.74, 95% CI 2.05–25.87), and septic shock (OR 56.41, 95% CI 11.11–458.37) were associated with mortality; adequate antimicrobial therapy was protective (OR 0.09, 95% CI 0.02–0.37). Conclusion: Clostridium spp. infections were associated with high mortality. Age and organ dysfunction were key risk factors, whereas early appropriate antimicrobial therapy was the main modifiable protective factor. Prompt recognition, timely antibiotics, and adequate source control are essential.
- 19 August 2026
- Published by Springer Nature in Discover Medicine
- Vol. 3 (1) , 111
Open AccessEpidemiology and predictors of 30-day mortality in clinically significant Clostridium species infections
Purpose: Clostridium species are an under-recognized cause of severe infections with substantial mortality, yet national data remain limited. This study aimed to characterize the epidemiological, microbiological, clinical, and therapeutic features of clinically significant Clostridium spp. infections and to identify factors associated with 30-day mortality. Methods: We conducted a retrospective, single-centre cohort study at Unidade Local de Saúde de Gaia-Espinho (Portugal), including all patients with clinically significant Clostridium spp. isolates between 1 January 2020 and 30 March 2025. Demographic, clinical, microbiological, and therapeutic data were obtained from electronic medical and laboratory records. The primary outcome was 30-day all-cause mortality. Survivors and non-survivors were compared using univariate and multivariable logistic regression analyses. Results: A total of 119 patients were included (median age 68.9 years). Most infections were community-acquired (73.1%), and C. perfringens was the most frequently identified species (58.8%). Thirty-day mortality was 22.7%. In univariate analysis, mortality was associated with older age, thrombocytopenia, hepatic and renal dysfunction, bacteremia, sepsis or septic shock, inadequate antimicrobial therapy, and lack of source control. In Firth penalised logistic regression, age (OR 1.09/year, 95% CI 1.04–1.16), hepatic dysfunction (OR 6.74, 95% CI 2.05–25.87), and septic shock (OR 56.41, 95% CI 11.11–458.37) were associated with mortality; adequate antimicrobial therapy was protective (OR 0.09, 95% CI 0.02–0.37). Conclusion: Clostridium spp. infections were associated with high mortality. Age and organ dysfunction were key risk factors, whereas early appropriate antimicrobial therapy was the main modifiable protective factor. Prompt recognition, timely antibiotics, and adequate source control are essential.